vision/eye
• stimulated lacrimal function is abolished compared to in similarly treated wild-type lacrimal gland fragments
• tear peroxidase declines in older mice
• lacrimal function is lost as early as 8 weeks
• lacrimal gland tissue produces more IL17 than in wild-type mice
• apoptosis in the lacrimal gland of young mice is increased compared to in wild-type mice
• mice exhibit deterioration in the lacrimal gland unlike wild-type mice
|
• apoptosis in the lacrimal gland of young mice is increased compared to in wild-type mice
|
• at 24 and 48 weeks, mononuclear infiltrates are increased compared to in wild-type mice
• mice exhibit an increase in CD4+ T cells compared with wild-type mice
|
• younger mice exhibit an increase in numbers goblet cells in the conjunctiva while in older mice they are decreased compared to in wild-type mice
|
• age-related decline in conjunctiva goblet cell density is worse than in wild-type mice
|
• older mice exhibit corneal edema unlike wild-type mice
|
• mice exhibit damage in the corneal epithelial barrier unlike wild-type mice
|
• mice exhibit a progressive reduction in eye size characterized by eye closure and eventual loss of the eye
|
• mice develop dry crusty eyes that eventually close
|
immune system
• at 24 and 48 weeks, mononuclear infiltrates are increased compared to in wild-type mice
• mice exhibit an increase in CD4+ T cells compared with wild-type mice
|
• in the lacrimal glands
|
• the number of Foxp3+ regulatory T cells in the spleen is decreased compared to in wild-type mice
|
• in splenocytes of older mice
|
• at 8 to 12 weeks, mice exhibit a 2-fold increase in IL17+ splenocytes compared with wild-type mice
• lacrimal gland tissue produces more IL17 than in wild-type mice
• in older mice, IL17 secretion from splenocytes is increased compared to in wild-type mice
|
• at 8 weeks, mice exhibit an increase in serum anti-SSA and anti-SSB autoantibodies compared with wild-type mice
|
hematopoietic system
• in the lacrimal glands
|
• the number of Foxp3+ regulatory T cells in the spleen is decreased compared to in wild-type mice
|
endocrine/exocrine glands
• stimulated lacrimal function is abolished compared to in similarly treated wild-type lacrimal gland fragments
• tear peroxidase declines in older mice
• lacrimal function is lost as early as 8 weeks
• lacrimal gland tissue produces more IL17 than in wild-type mice
• apoptosis in the lacrimal gland of young mice is increased compared to in wild-type mice
• mice exhibit deterioration in the lacrimal gland unlike wild-type mice
|
• apoptosis in the lacrimal gland of young mice is increased compared to in wild-type mice
|
• at 24 and 48 weeks, mononuclear infiltrates are increased compared to in wild-type mice
• mice exhibit an increase in CD4+ T cells compared with wild-type mice
|
cardiovascular system
• DEA/NO treatment causes a greater hypotensive effect than in controls
|
• significantly decreased relative to controls
|
• dark cycle mean arterial pressure is significantly increased relative to controls
|
• dark cycle diastolic pressure is increased relative to controls
|
integument
• hair is preserved after 25 Gy irradiation
• minimal or no skin ulceration 8 weeks after irradiation
• hair follicles and skin architecture are better preserved than in controls
|
muscle
N |
• no leg muscle atrophy after irradiation
• limb flexibility maintained
|
• less loss of muscle fibers and nuclei after irradiation
|
cellular
N |
• mitochondrial viability and function is preserved after irradiation
|
• apoptosis in the lacrimal gland of young mice is increased compared to in wild-type mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Sjogren's syndrome | DOID:12894 |
OMIM:270150 |
J:153126 |